FDA Notifications and Medwatch Form Requirements Adverse Event Reporting for OTC Drugs and Dietary Supplements.

Slides:



Advertisements
Similar presentations
10/20/ The Pharmaceutical Industry and Their Influence on Pain Management in the ED J. David Haddox, DDS, MD VP, Risk Management & Health Policy.
Advertisements

Safety Reporting IN Clinical Trials
Adverse Event Reporting. Reporting Adverse Events Adverse Events (AEs) are “... any untoward medical occurrence in a subject that was not previously identified.
ALERT: The Basics Food and Drug Administration Center for Food Safety and Applied Nutrition.
© 2005 Notification and Reporting on Food Incidents: Irish Approach Food & Drugs Authority Bangkok Thailand Dorothy Guina-Dornan.
Introduction to Regulation
Field Investigators: ADE Detectives. Section One Introduction to the Team and Their Roles.
MONDAY, 5:00 – 5:30PM Innovative Opportunities for Patient Safety Using Electronic Health Record (EHR) Data: Perspectives from the FDA FDA to CONNECT Mitra.
Basic Pharmacovigilance Training
FDA’s MedWatch Program Outreach to Healthcare Professionals and the Public n Managing the Risks of Medical Product Use.
Dietary Supplements Guidance for Consumers Information Provided To You By: JFHQ Occupational Health Office Nutrition For Everyday Series- Lesson 9.
FDA MedWatch and Patient Safety. Dietary Supplement and Nonprescription Drug Consumer Protection Act of 2006  The Act defines a ‘serious adverse event’
FDA Recalls Risk Communication Advisory Committee David K. Elder Director, Office of Enforcement.
Christian Asher.  there are more than 50,000 Dietary supplements available on the market today.  Dietary supplements are more popular than they’ve ever.
Dietary Supplements Bradford W. Williams Special Assistant Division of Dietary Supplement Programs ONPLDS, CFSAN, FDA.
Requirements of EU pharmacovigilance legislation for distributors Julia Sipos Quality Management Director Pharmacovigilance coordinator Version 03.
POSTMARKETING ADVERSE DRUG EXPERIENCE INSPECTIONAL PROGRAM CDR Thomas R. Berry, RPh FDA, Investigator RAL-RP / ATL-DO.
Ken Falci, Ph.D.,Director, OSAS Center for Food Safety and Applied Nutrition (CFSAN) FDA, College Park, MD.
SERIOUS ADVERSE EVENTS REPORTING Elizabeth Dayag IRB Administrator Naval Medical Center Portsmouth.
Center for Veterinary Medicine (CVM) RECALLS.  21 CFR 7.40 provides guidance on the policy, procedures, and industry responsibilities for recalls. 
Council for Responsible Nutrition Supplyside West, October 19, 2006 The Case for Mandatory Reporting of Adverse Events for Dietary Supplements Steve Mister.
Adverse Events and Unanticipated Problems Presented by: Karen Jeans, PhD, CCRN, CIP COACH Program Analyst.
Patient Safety and Medical Devices Sonia Swayze, RN, MA, C and Suzanne Rich, RN, MA, CT.
eCTD: Module 1 from submission to reviewer
Marc R. Blackman, M.D. Associate Chief of Staff, Research & Development Washington DC VA Medical Center Professor of Medicine Johns Hopkins University.
Adverse Event Reporting.
Investigational New Drug Application (IND)
Life Sciences Research Office (LSRO) Evaluating Adverse Event Reporting Systems for Dietary Supplements January 30-31, 2003 “Open Portion of Meeting”
Reporting Adverse Effects. What to report? (you do not need to be certain, just suspicious!) ADRAC encourages the reporting of all suspected adverse reactions.
PHARMACOVIGILANCE AND CLINICAL TRIALS DIVISION 20 August 2015 Victoria Falls Protecting Your Right to Quality Medicines and Medical Devices.
Dietary Supplements. Definition by DSHEA Product that is to supplement a healthy diet. Includes ingredients such as vitamins, minerals, herbs, botanicals,
Implementation of the Proposed Canada Consumer Product Safety Act (Bill C-6) Mandatory Reporting Health Canada ICPHSO 2009, Toronto.
Bibliography Amoore, J., Ingram, P. (2002, August). Quality improvement report: Learning from adverse incidents involving medical devices. British Medical.
Council for Responsible Nutrition FDA Public Meeting on New Dietary Ingredients Annette Dickinson, Ph.D. November 15, 2004.
DIETARY SUPPLEMENTS Dietary supplements are products that can be added to people’s diets. They include vitamins, minerals, herbs, and amino acids.
EAE Training EAE Reporting and Assessment Overview DAIDS Regional Training Event, Regulatory Compliance Center Kampala, Uganda, September 2009 DAIDS Regional.
Overview of FDA's Regulatory Framework for PET Drugs
Rules for Supporting Part 803 and Part 806 Decision Making Page 1 Establishing Rules for: Medical Device Reports (803) & Correction and Removal Reports.
1 Serious Adverse Events Following Falsely Elevated Glucose Measurements Resulting from Administration of an IGIV Product Containing Maltose BPAC Meeting,
Practical Implications of Electrical Product Safety Regulation in Ontario International Consumer Product Health and Safety Organization Sixth International.
Defining Dietary Supplements Provided Courtesy of RD411.com Where dietitians go for information Review Date 11/11 G-0519.
FDA Regulatory and Compliance Symposium
Office of Research Oversight 1 Office of Research and Development Local Accountability Meeting January 2009.
FDA job description  Regulates about 25% of all consumer purchases  Mission summary: protect and advance public health  Products: food, cosmetics, drugs,
European Patients’ Academy on Therapeutic Innovation Introduction to pharmacovigilance Monitoring the safety of medicines.
Janet McDonald, Ph.D., R.D. Regulation of Food & Dietary Supplements.
U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only.
FDA Risk Communication Nancy M. Ostrove, PhD Senior Advisor for Risk Communication Risk Communication Advisory Committee February 28, 2008.
Special Dietary Needs Resources Beth Foland, MS,RD I DOE February, 2016.
CPSC Data Bases Tom Schroeder 3/11 *This presentation was prepared by CPSC staff. It has not been reviewed or approved by, and may not necessarily reflect.
Evaluating Your Nutritional Supplement – Are You Buying The Right Vitamins?
Reporting Adverse Events from Dietary Supplements (For the Warfighter) DoD Human Performance Resource Center Website address: hprc-online.org Contact
Nutritional Supplements An Issue Everyone Needs to Know.
Office of Human Research (OHR) Quality Improvement Program Patrick Herbison Heather Krupinski.
Complaint Handling Medical Device Reporting May 19, 2016 Rita Harden, Director Customer Relations & Regulatory Reporting.
Medicines Authority 203,Level 3, Rue D’Argens, Gzira,GZR 1368 Tel: (+356) Fax: (+356) ov.mt Reporting.

The Working Group on Medical Measurements The 23rd Forum Meeting
FHIR Adverse Event Resource
Dietary and Herbal Supplements
Remote Monitoring of Adverse Events
Vitamins, herbs, and nutritional supplements
Dietary Supplements: What you should know
A “Successful” FDA Submission: Key Components Needed
Remote Monitoring of Adverse Events
Overview of FDA Food Inspections
Patient details Health number: this may be a national identifier (preferred), hospital, clinic, or program number Name: full name is preferable as an accurate.
Patient Involvement in the Development and Safe Use of
Model Enhanced Classification of Serious Adverse Events
Protecting Canadians from Unsafe Drugs Act
Presentation transcript:

FDA Notifications and Medwatch Form Requirements Adverse Event Reporting for OTC Drugs and Dietary Supplements

The Background – What You Need to Know Adverse Event (AE) reporting regulations implement the Dietary Supplement & OTC Drug Consumer Protection Act of 2006 (Public Law ). FDA regulations for adverse event reporting went into effect in December Product label must contain the address (street address or P.O. Box) or phone number at which company or other responsible person will receive a serious adverse event report. Serious Adverse Event (SAE) reporting is required for all OTC Drugs and Dietary Supplements.

Products That Are Covered All OTC monographed drugs (Rx to OTC drugs are already required to report AEs). All dietary supplements including vitamins, minerals, herbal or other botanical products, amino acids, or any dietary substance used to supplement the diet by increasing the total dietary intake. When the Personal Care Products Safety Act becomes law, cosmetics will also be covered.

Death: Report if the patient’s death is suspected of being associated with use of the product by the patient. Life-Threatening: Report if the person was at substantial risk of dying at time of the adverse event or if suspected that continued use of product could result in a person’s death. Hospitalization: Report if admission to the hospital was caused by or related to an adverse event associated with use of the product. Emergency Room treatment is sometimes reported too. Disability: Report if the adverse event resulted in a significant or permanent change, impairment or damage to the person’s body function/structure or quality of life. Spontaneous abortion, congenital anomaly or birth defect associated with a product use must also be reported to the FDA. Definition of a Serious Adverse Event (SAE) Section 761(a)(2) of the F,D, & C Act

FDA Notifications - Voluntary SAE Reporting FDA encourages healthcare professionals to report serious adverse events to the agency for tracking purposes. FDA’s Center for Food Safety & Applied Nutrition (CFSAN) Adverse Event Reporting System (CAERS) collects reports about adverse events and product complaints related to CFSAN regulated products, including foods, dietary supplements and cosmetics. CFSAN encourages voluntary AE reports for cosmetics and conventional foods. If a company receives a report of a serious adverse event, you should report it to CAERS even if reporting isn’t mandatory for the product (e.g. a food or cosmetic).

FDA Notifications Many serious adverse events are reported to FDA directly by consumers, hospitals, or healthcare professionals. If FDA receives a serious adverse event report about a company’s product they will contact you and you must keep that report on file. Often FDA notification comes with a request for more information and submission of a Medwatch form with product label.

Medwatch Form Requirements (Form 3500A) Medwatch form must identify the injured person (name, age, sex, full address, etc.). Initials are used to protect privacy. An identifiable initial reporter of the event. Identity and contact information for the responsible party (i.e. the manufacturer, packer, or distributor representative submitting the AE report to FDA). Name of the specific product that is suspected of causing the adverse event (not just a brand name). Description of the serious adverse event with outcome.

Address for Medwatch Form Hard Copy Submission DIETARY SUPPLEMENTS: FAX NUMBER FOR ALL AEs: FDA Center Food Safety & Nutrition Office of Food Defense, HFS Paint Brach Parkway College Park, MD OTC DRUGS: FDA Center Drug Evaluation & Research Central Document Room 5901-B Ammendale Road Beltsville, MD

Online Reporting of Medwatch Forms Or Go to the FDA website ( click on “Drugs” and enter “MEDWATCH form”. Click on “Download form” or click on “Recalls & Alerts” and see bullet called “MEDWATCH.” Click on “Report serious adverse events online.”

Thank You For organizational training on adverse event reporting and FDA compliance, visit